Fried V A
J Biol Chem. 1981 Jan 10;256(1):244-52.
A mutant in the Escherichia coli lac permease, called Yf, appears to be defective in the biogenesis and proper assembly of this membrane protein. It was proposed that this defect led to the accumulation of a precursor of the mutant permease (Fried, V. A. (1977) J. Mol Biol. 114, 477-490). In this communication, evidence is presented that the lacYf mutant accumulates a novel lac-specific soluble polypeptide with a molecular weight of 87,000. Detected by double-label analysis on sodium dodecyl sulfate gels, and identified as a lac-specific polypeptide on a two-dimensional gel system, this polypeptide is immunoprecipitated by anti-transacetylase antibody. Pulse-chase experiments are consistent with the hypothesis that it is converted in vivo into a lac-specific membrane protein with an apparent molecular weight of 28,000, which appears to be the mutant lac permease. The results suggest that the 87,000-dalton soluble protein is a precursor of the mutant lac permease. It is proposed that this precursor is a polyprotein chimera containing both the lacY and lacA gene products.
大肠杆菌乳糖通透酶的一个突变体,称为Yf,似乎在这种膜蛋白的生物合成和正确组装方面存在缺陷。有人提出,这种缺陷导致了突变通透酶前体的积累(弗里德,V.A.(1977年)《分子生物学杂志》114卷,477 - 490页)。在本通讯中,有证据表明lacYf突变体积累了一种分子量为87,000的新型乳糖特异性可溶性多肽。通过十二烷基硫酸钠凝胶上的双标记分析检测到,并在二维凝胶系统上鉴定为乳糖特异性多肽,该多肽可被抗转乙酰酶抗体免疫沉淀。脉冲追踪实验与以下假设一致,即它在体内转化为一种表观分子量为28,000的乳糖特异性膜蛋白,该蛋白似乎是突变的乳糖通透酶。结果表明,87,000道尔顿的可溶性蛋白是突变乳糖通透酶的前体。有人提出,这种前体是一种包含lacY和lacA基因产物的多蛋白嵌合体。